Therapeutic response to an empirical praziquantel treatment in long-staying sub-Saharan African migrants with positive Schistosoma serology and chronic symptoms: A prospective cohort study in Spain
Authors:
Open Access
- 11 March 2025
- journal article
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 154, 107873
Abstract
No abstract availableKeywords
Funding Information
- Fundació Lluita contra les Infeccions
This publication has 30 references indexed in Scilit:
- Morbidity burden of imported chronic schistosomiasis among West African migrantsJournal of Infection, 2024
- Consensus definitions in imported human schistosomiasis: a GeoSentinel and TropNet Delphi studyThe Lancet Infectious Diseases, 2024
- Chronic schistosomiasis imported in France: A retrospective multicentre analysis of 532 patients, calling for international recommendationsTravel Medicine and Infectious Disease, 2023
- Praziquantel: An update on the mechanism of its action against schistosomiasis and new therapeutic perspectivesMolecular and Biochemical Parasitology, 2022
- Intestinal schistosomiasis: a very long-lived tropical parasiteClinical Microbiology and Infection, 2019
- Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysisThe Lancet Global Health, 2019
- The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan AfricaInfection, 2019
- Serological approaches for the diagnosis of schistosomiasis – A reviewMolecular and Cellular Probes, 2017
- Spatial distribution of schistosomiasis and treatment needs in sub-Saharan Africa: a systematic review and geostatistical analysisThe Lancet Infectious Diseases, 2015
- Human schistosomiasisThe Lancet, 2014